Phase 2a/b read out by end of 2024 for market cap of $8M, if your thinking positive outcome, not sure there is equatable value on the asx right now.
But, from my understanding cash is pretty low per their last quarterly, is a cap raise imminent or perhaps I missed something?
Ann: Phase 2a/b clinical trial update, page-2
Add ILA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $11.07K | 97.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 102533 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 45169 | 2 |
View Market Depth
| Last trade - 15.24pm 05/11/2024 (20 minute delay) ? |
| ILA (ASX) Chart |